The Safety and Efficacy of CART-19 Cells in B-cell Acute Lymphoblastic Leukemia (B-ALL).
Clinical trial NCT02924753 · UNKNOWN
Trial details
- NCT number
- NCT02924753
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-18
- Primary completion
- 2019-07-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.